The Cold War, The Lavender Scare, and the Untold Story of Eisenhower's First National Security Advisor. President Eisenhower's National Security Advisor Robert "Bobby" Cutler -- working alongside Ike and also the Dulles brothers at the CIA and State Department -- shaped US Cold War strategy in far more consequential ways than previously understood. A lifelong Republican, Cutler also served three Democratic presidents. A charming raconteur, he was a tight-lipped loyalist who worked behind the scenes to get things done. Cutler was in love with a man half his age, naval intelligence officer and NSC staffer Skip Koons. Cutler poured his emotions into a six-volume diary and dozens of letters that have been hidden from history. Steve Benedict, who was White House security officer, Cutlers' friend and Koons' friend and former lover, preserved Cutler's papers. All three men served Eisenhower at a time when anyone suspected of "sexual perversion", i.e. homosexuality, was banned from federal employment and vulnerable to security sweeps by the FBI. This gripping account reveals in fascinating detail Cutler's intimate thoughts and feelings about US efforts to confront Soviet expansion and aggression while having to contend with the reality that tens of millions of people would die in a first nuclear strike, and that a full nuclear exchange would likely lead to human extinction. And Shinkle recounts with sensitivity the daily challenges and personal dramas of a small but representative group or patriotic gay men who were forced to hide essential aspects of who they were in order to serve a president they admired and a country they loved.
This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work. This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.
Organizations today are more widely distributed than ever before, which can make systems management tasks, such as distributing software, patches, and security policies, extremely challenging. The IBM® Tivoli® Endpoint Manager platform is architected for today's highly diverse, distributed, and complex IT environments. It provides real-time visibility and control through a single infrastructure, single agent, and single console for systems lifecycle management, endpoint protection, and security configuration and vulnerability management. This platform enables organizations to securely manage their global IT infrastructures faster and more accurately, resulting in improved governance, control, visibility, and business agility. Plus, it gives organizations the ability to handle tomorrow's unforeseen challenges. In this IBM Redbooks® publication, we provide IT security professionals with a better understanding around the challenging topic of endpoint management in the IT security domain. We focus on IBM Tivoli Endpoint Manager for Security and Compliance and describe the product architecture and provide a hands-on design guide for deploying the solution. This book is a valuable resource for security professionals and architects who want to understand and implement a centralized endpoint management infrastructure and endpoint protection to better handle security and compliance challenges.
Covering the latest advances in CNS drug development, this bookwill guide all those involved in pre-clinical to early clinicaltrials. The authors describe how recent innovations can acceleratethe development of novel CNS compounds, improve early detection ofefficacy and toxicity signals, and increase the safety oflater-stage clinical trials. The current crisis in the drug development industry iscritically reviewed, as well as the steps needed to correct theproblems, including new government-backed regulations andindustry-based innovations designed to accelerate CNS drugdevelopment in the future. Animal-based models of major CNS disorders are described indetail, and the ability of the latest in vitro and computer-basedmodels to simulate CNS disease states and predict drug efficacy andside-effects are examined. Particular attention is given tothe growing use of biomarkers and how they can be used effectivelyin early human trials as signals of potential drug efficacy, aswell as the increasingly important role of imaging studies to guidedose selection. Cognitive assessments that can be useful indicatorsof effect in patient populations are also discussed. Written by a team of clinical scientists involved in CNS drugtrials for over 20 years, and based on a wealth of drug developmentand clinical trial experience, Critical Pathways to Success inCNS Drug Developmentis full of practical advice forsuccessfully designing and executing CNS drug trials, avoidingpotential pitfalls, and complying with government regulations
When the town's newspaper office is burned to the ground and the owner murdered, suspicion falls on Lane Cutler, the young deputy marshal of Progress. His alibi - that he was being held prisoner by ruffians at the time of the killing - persuades veteran lawman Ben McCabe to go in search of the truth. But the marshal runs into a wall of silence, shored up by blackmail and revenge. And when death strikes again, McCabe must join forces with a stranger before the final showdown...
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.